InvestorsHub Logo
Followers 145
Posts 27556
Boards Moderated 3
Alias Born 02/07/2004

Re: TechKim post# 173

Friday, 03/31/2017 1:16:28 PM

Friday, March 31, 2017 1:16:28 PM

Post# of 651
The only crucial issue now, to
make (or break) the company is
the results of the European
ongoing Phase 2b trial.
Well, Q2 2017 is not that far
away!

BTW i am very much encouraged by:

Dr. Shimon Hassin, BiondVax's COO noted, "In the past few years BiondVax focused on establishing a small scale GMP facility, one that was approved by the European Union. Our current facility laid the foundation for manufacturing quality excellence that will be implemented in the new factory."

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BVXV News